Polymatin A from Smallanthus macroscyphus leaves: a safe and promising antidiabetic compound

SERRA BARCELLONA C.; HABIB N.C.; HONORE S.M.; CABRERA W.M.; GENTA S.B.; SANCHEZ S.S.

JOURNAL OF APPLIED TOXICOLOGY

JOHN WILEY & SONS LTD

Lugar: Londres; Año: 2016 p. 1516 - 1525

0260-437X

Smallanthus macroscyphus is an herb native to South America whose leaves are a source of anti-diabetic compounds, although complete information about their safe use is not available yet. This study was developed to evaluate the toxicity profile of both 10% decoction and polymatin A from S. macroscyphus leaves through in vitro cytotoxicity assays and in vivo subchronic oral toxicity. Cell viability of Hep-G2, COS1, CHO-K1 and Vero cell lines decreased in a concentration-dependent manner when cells were incubated with 0.4-200.0 µg of dry extract /mL or 0.12-60.00 µg of polymatin A/mL. In sub-chronic studies, decoction was orally administered to Wistar rats for 90 days at daily doses of 70, 140 and 280 mg dry extract/kg, whereas polymatin A was administered in the same way at doses of 7, 14 and 28 mg /kg. No toxicity signs or deaths were observed. There were no changes in the behavior, body or organ weights, hematological, biochemical or urine parameters of the rats. No histopathological lesions were observed in the examined organs. The results indicate that the 10% decoction and polymatin A from S. macroscyphus leaves may be considered as non-toxic substances at a wide range of doses, including the effective hypoglycemic dose.